334 related articles for article (PubMed ID: 27931779)
1. Complement and sepsis-induced heart dysfunction.
Fattahi F; Ward PA
Mol Immunol; 2017 Apr; 84():57-64. PubMed ID: 27931779
[TBL] [Abstract][Full Text] [Related]
2. Complement Destabilizes Cardiomyocyte Function In Vivo after Polymicrobial Sepsis and In Vitro.
Kalbitz M; Fattahi F; Herron TJ; Grailer JJ; Jajou L; Lu H; Huber-Lang M; Zetoune FS; Sarma JV; Day SM; Russell MW; Jalife J; Ward PA
J Immunol; 2016 Sep; 197(6):2353-61. PubMed ID: 27521340
[TBL] [Abstract][Full Text] [Related]
3. Role of complement C5a and histones in septic cardiomyopathy.
Fattahi F; Frydrych LM; Bian G; Kalbitz M; Herron TJ; Malan EA; Delano MJ; Ward PA
Mol Immunol; 2018 Oct; 102():32-41. PubMed ID: 29914696
[TBL] [Abstract][Full Text] [Related]
4. An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.
Niederbichler AD; Hoesel LM; Westfall MV; Gao H; Ipaktchi KR; Sun L; Zetoune FS; Su GL; Arbabi S; Sarma JV; Wang SC; Hemmila MR; Ward PA
J Exp Med; 2006 Jan; 203(1):53-61. PubMed ID: 16380509
[TBL] [Abstract][Full Text] [Related]
5. Complement-induced activation of MAPKs and Akt during sepsis: role in cardiac dysfunction.
Fattahi F; Kalbitz M; Malan EA; Abe E; Jajou L; Huber-Lang MS; Bosmann M; Russell MW; Zetoune FS; Ward PA
FASEB J; 2017 Sep; 31(9):4129-4139. PubMed ID: 28572445
[TBL] [Abstract][Full Text] [Related]
6. Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.
Colley CS; Popovic B; Sridharan S; Debreczeni JE; Hargeaves D; Fung M; An LL; Edwards B; Arnold J; England E; Eghobamien L; Sivars U; Flavell L; Renshaw J; Wickson K; Warrener P; Zha J; Bonnell J; Woods R; Wilkinson T; Dobson C; Vaughan TJ
MAbs; 2018 Jan; 10(1):104-117. PubMed ID: 28952876
[TBL] [Abstract][Full Text] [Related]
7. Complement-induced activation of the cardiac NLRP3 inflammasome in sepsis.
Kalbitz M; Fattahi F; Grailer JJ; Jajou L; Malan EA; Zetoune FS; Huber-Lang M; Russell MW; Ward PA
FASEB J; 2016 Dec; 30(12):3997-4006. PubMed ID: 27543123
[TBL] [Abstract][Full Text] [Related]
8. Harmful Roles of TLR3 and TLR9 in Cardiac Dysfunction Developing during Polymicrobial Sepsis.
Fattahi F; Russell MW; Malan EA; Parlett M; Abe E; Zetoune FS; Ward PA
Biomed Res Int; 2018; 2018():4302726. PubMed ID: 30364002
[TBL] [Abstract][Full Text] [Related]
9. New strategies for treatment of infectious sepsis.
Ward PA; Fattahi F
J Leukoc Biol; 2019 Jul; 106(1):187-192. PubMed ID: 30821872
[TBL] [Abstract][Full Text] [Related]
10. Distinct neutrophil C5a receptor inflammatory events in cows initiated by chemoattractant C5a and lipopolysaccharide around parturition and in mid lactation.
Boulougouris X; Rogiers C; Van Poucke M; De Spiegeleer B; Peelman LJ; Duchateau L; Burvenich C
J Dairy Sci; 2019 Feb; 102(2):1457-1472. PubMed ID: 30594380
[TBL] [Abstract][Full Text] [Related]
11. C5a-blockade improves burn-induced cardiac dysfunction.
Hoesel LM; Niederbichler AD; Schaefer J; Ipaktchi KR; Gao H; Rittirsch D; Pianko MJ; Vogt PM; Sarma JV; Su GL; Arbabi S; Westfall MV; Wang SC; Hemmila MR; Ward PA
J Immunol; 2007 Jun; 178(12):7902-10. PubMed ID: 17548628
[TBL] [Abstract][Full Text] [Related]
12. Complement as a Major Inducer of Harmful Events in Infectious Sepsis.
Fattahi F; Zetoune FS; Ward PA
Shock; 2020 Nov; 54(5):595-605. PubMed ID: 32187106
[TBL] [Abstract][Full Text] [Related]
13. Role of extracellular histones in the cardiomyopathy of sepsis.
Kalbitz M; Grailer JJ; Fattahi F; Jajou L; Herron TJ; Campbell KF; Zetoune FS; Bosmann M; Sarma JV; Huber-Lang M; Gebhard F; Loaiza R; Valdivia HH; Jalife J; Russell MW; Ward PA
FASEB J; 2015 May; 29(5):2185-93. PubMed ID: 25681459
[TBL] [Abstract][Full Text] [Related]
14. Cutting edge: critical role for C5aRs in the development of septic lymphopenia in mice.
Grailer JJ; Fattahi F; Dick RS; Zetoune FS; Ward PA
J Immunol; 2015 Feb; 194(3):868-72. PubMed ID: 25539817
[TBL] [Abstract][Full Text] [Related]
15. Complement dependency of cardiomyocyte release of mediators during sepsis.
Atefi G; Zetoune FS; Herron TJ; Jalife J; Bosmann M; Al-Aref R; Sarma JV; Ward PA
FASEB J; 2011 Jul; 25(7):2500-8. PubMed ID: 21478262
[TBL] [Abstract][Full Text] [Related]
16. C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma.
Nabizadeh JA; Manthey HD; Panagides N; Steyn FJ; Lee JD; Li XX; Akhir FNM; Chen W; Boyle GM; Taylor SM; Woodruff TM; Rolfe BE
FASEB J; 2019 Oct; 33(10):11060-11071. PubMed ID: 31298935
[TBL] [Abstract][Full Text] [Related]
17. Complement C5a Functions as a Master Switch for the pH Balance in Neutrophils Exerting Fundamental Immunometabolic Effects.
Denk S; Neher MD; Messerer DAC; Wiegner R; Nilsson B; Rittirsch D; Nilsson-Ekdahl K; Weckbach S; Ignatius A; Kalbitz M; Gebhard F; Weiss ME; Vogt J; Radermacher P; Köhl J; Lambris JD; Huber-Lang MS
J Immunol; 2017 Jun; 198(12):4846-4854. PubMed ID: 28490576
[TBL] [Abstract][Full Text] [Related]
18. Role of C5 activation products in sepsis.
Ward PA
ScientificWorldJournal; 2010 Dec; 10():2395-402. PubMed ID: 21170490
[TBL] [Abstract][Full Text] [Related]
19. Complement 5a receptor-mediated neutrophil dysfunction is associated with a poor outcome in sepsis.
Xu R; Lin F; Bao C; Huang H; Ji C; Wang S; Jin L; Sun L; Li K; Zhang Z; Wang FS
Cell Mol Immunol; 2016 Jan; 13(1):103-9. PubMed ID: 25726869
[TBL] [Abstract][Full Text] [Related]
20. C5aR2 receptor: The genomic twin of the flamboyant C5aR1.
Das A; Gupta PK; Rana S
J Cell Biochem; 2022 Nov; 123(11):1841-1856. PubMed ID: 35977039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
